Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Bafaloukos

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Indian Journal of Dermatology|June 1, 2019
Nodular Lesions on the Upper Trunk: An Uncommon Anatomical Site of Renal Tumor MetastasesNikolaos Kostopoulos, Eftychia Platsidaki, Vasiliki Tzanetakou, et al.
Immunotherapy|September 11, 2024
Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicityDimitrios Bafaloukos, Ioanna Gazouli, Aikaterini Bousmpoukea, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma PatientGeorge Samonis, Aikaterini Bousmpoukea, Aristea Molfeta, et al.
Maedica|December 21, 2022
Soleus Muscle Single Metastasis from Hepatocellular CarcinomaChristos Koutserimpas, Nikolaos Dargaras, Symeon Naoum, et al.
Tumori|November 10, 2005
Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG)Eleni Timotheadou, Pavlos Papakostas, Dimitrios Tsavdaridis, et al.
Journal of Neuro-Oncology|February 19, 2005
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyChristos Christodoulou, Dimitrios Bafaloukos, Helen Linardou, et al.
Anticancer Research|February 11, 2015
Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG)Helena Linardou, George Pentheroudakis, Ioannis Varthalitis, et al.
Gynecologic Oncology|May 6, 2008
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) studyChristos A Papadimitriou, Dimitrios Bafaloukos, George Bozas, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)Christos Christodoulou, Haralambos P Kalofonos, Evangelos Briasoulis, et al.
The Lancet. Oncology|September 23, 2008
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerHelena Linardou, Issa J Dahabreh, Dimitra Kanaloupiti, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Indian Journal of Dermatology|June 1, 2019
Nodular Lesions on the Upper Trunk: An Uncommon Anatomical Site of Renal Tumor MetastasesNikolaos Kostopoulos, Eftychia Platsidaki, Vasiliki Tzanetakou, et al.
Immunotherapy|September 11, 2024
Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicityDimitrios Bafaloukos, Ioanna Gazouli, Aikaterini Bousmpoukea, et al.
Diagnostics (Basel, Switzerland)|November 26, 2022
Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma PatientGeorge Samonis, Aikaterini Bousmpoukea, Aristea Molfeta, et al.
Maedica|December 21, 2022
Soleus Muscle Single Metastasis from Hepatocellular CarcinomaChristos Koutserimpas, Nikolaos Dargaras, Symeon Naoum, et al.
Tumori|November 10, 2005
Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG)Eleni Timotheadou, Pavlos Papakostas, Dimitrios Tsavdaridis, et al.
Journal of Neuro-Oncology|February 19, 2005
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II studyChristos Christodoulou, Dimitrios Bafaloukos, Helen Linardou, et al.
Anticancer Research|February 11, 2015
Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG)Helena Linardou, George Pentheroudakis, Ioannis Varthalitis, et al.
Gynecologic Oncology|May 6, 2008
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) studyChristos A Papadimitriou, Dimitrios Bafaloukos, George Bozas, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2005
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)Christos Christodoulou, Haralambos P Kalofonos, Evangelos Briasoulis, et al.
The Lancet. Oncology|September 23, 2008
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerHelena Linardou, Issa J Dahabreh, Dimitra Kanaloupiti, et al.
Pageof 11